Literature DB >> 36018438

Exogenous Adenosine Modulates Behaviors and Stress Response in Caenorhabditis elegans.

Thayanara Cruz da Silva1, Tássia Limana da Silveira1, Luiza Venturini Dos Santos1, Leticia Priscila Arantes2, Rodrigo Pereira Martins1, Félix Alexandre Antunes Soares1, Cristiane Lenz Dalla Corte3.   

Abstract

Adenosine, a purine nucleoside with neuromodulatory actions, is part of the purinergic signaling system (PSS). Caenorhabditis elegans is a free-living nematode found in soil, used in biological research for its advantages as an alternative experimental model. Since there is a lack of evidence of adenosine's direct actions and the PSS's participation in this animal, such an investigation is necessary. In this research, we aimed to test the effects of acute and chronic adenosine at 1, 5, and 10 mM on nematode's behaviors, morphology, survival after stress conditions, and on pathways related to the response to oxidative stress (DAF-16/FOXO and SKN-1) and genes products downstream these pathways (SOD-3, HSP-16.2, and GCS-1). Acute or chronic adenosine did not alter the worms' morphology analyzed by the worms' length, width, and area, nor interfered with reproductive behavior. On the other hand, acute and chronic adenosine modulated the defecation rate, pharyngeal pumping rate, and locomotion, in addition, to interacting with stress response pathways in C. elegans. Adenosine interfered in the speed and mobility of the worms analyzed. In addition, both acute and chronic adenosine presented modulatory effects on oxidative stress response signaling. Acute adenosine prevented the heat-induced-increase of DAF-16 activation and SOD-3 levels, while chronic adenosine per se induced DAF-16 activation and prevented heat-induced-increase of HSP-16.2 and SKN-1 levels. Together, these results indicate that exogenous adenosine has physiological and biochemical effects on C. elegans and describes possible purinergic signaling in worms.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adenosine; Behavior; Caenorhabditis elegans; Oxidative stress; Purinergic system

Year:  2022        PMID: 36018438     DOI: 10.1007/s11064-022-03727-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  57 in total

1.  A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice.

Authors:  J F Chen; Z Huang; J Ma; J Zhu; R Moratalla; D Standaert; M A Moskowitz; J S Fink; M A Schwarzschild
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

2.  Selective amplification and cloning of four new members of the G protein-coupled receptor family.

Authors:  F Libert; M Parmentier; A Lefort; C Dinsart; J Van Sande; C Maenhaut; M J Simons; J E Dumont; G Vassart
Journal:  Science       Date:  1989-05-05       Impact factor: 47.728

Review 3.  Pharmacology of Adenosine Receptors: The State of the Art.

Authors:  Pier Andrea Borea; Stefania Gessi; Stefania Merighi; Fabrizio Vincenzi; Katia Varani
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

4.  Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance.

Authors:  Alexei Verkhratsky; Geoffrey Burnstock
Journal:  Bioessays       Date:  2014-04-30       Impact factor: 4.345

Review 5.  Nomenclature and classification of purinoceptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; J W Daly; T K Harden; K A Jacobson; P Leff; M Williams
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

Review 6.  Adenosine, oxidative stress and cytoprotection.

Authors:  V Ramkumar; D M Hallam; Z Nie
Journal:  Jpn J Pharmacol       Date:  2001-07

Review 7.  Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.

Authors:  Catarina V Gomes; Manuella P Kaster; Angelo R Tomé; Paula M Agostinho; Rodrigo A Cunha
Journal:  Biochim Biophys Acta       Date:  2010-12-09

Review 8.  Neuroprotective role of adenosine in cerebral ischaemia.

Authors:  K A Rudolphi; P Schubert; F E Parkinson; B B Fredholm
Journal:  Trends Pharmacol Sci       Date:  1992-12       Impact factor: 14.819

Review 9.  Immunity, inflammation and cancer: a leading role for adenosine.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Nat Rev Cancer       Date:  2013-11-14       Impact factor: 60.716

Review 10.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.